BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 22843265)

  • 21. Analysis of the C9orf72 hexanucleotide repeat expansion in Korean patients with familial and sporadic amyotrophic lateral sclerosis.
    Jang JH; Kwon MJ; Choi WJ; Oh KW; Koh SH; Ki CS; Kim SH
    Neurobiol Aging; 2013 Apr; 34(4):1311.e7-9. PubMed ID: 23088937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia.
    Dols-Icardo O; García-Redondo A; Rojas-García R; Sánchez-Valle R; Noguera A; Gómez-Tortosa E; Pastor P; Hernández I; Esteban-Pérez J; Suárez-Calvet M; Antón-Aguirre S; Amer G; Ortega-Cubero S; Blesa R; Fortea J; Alcolea D; Capdevila A; Antonell A; Lladó A; Muñoz-Blanco JL; Mora JS; Galán-Dávila L; Rodríguez De Rivera FJ; Lleó A; Clarimón J
    Hum Mol Genet; 2014 Feb; 23(3):749-54. PubMed ID: 24057670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VCP mutations are not a major cause of familial amyotrophic lateral sclerosis in the UK.
    Kwok CT; Wang HY; Morris AG; Smith B; Shaw C; de Belleroche J
    J Neurol Sci; 2015 Feb; 349(1-2):209-13. PubMed ID: 25618255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72.
    Boeve BF; Boylan KB; Graff-Radford NR; DeJesus-Hernandez M; Knopman DS; Pedraza O; Vemuri P; Jones D; Lowe V; Murray ME; Dickson DW; Josephs KA; Rush BK; Machulda MM; Fields JA; Ferman TJ; Baker M; Rutherford NJ; Adamson J; Wszolek ZK; Adeli A; Savica R; Boot B; Kuntz KM; Gavrilova R; Reeves A; Whitwell J; Kantarci K; Jack CR; Parisi JE; Lucas JA; Petersen RC; Rademakers R
    Brain; 2012 Mar; 135(Pt 3):765-83. PubMed ID: 22366793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The frequency of the C9orf72 expansion in a Brazilian population.
    Cintra VP; Bonadia LC; Andrade HMT; de Albuquerque M; Eusébio MF; de Oliveira DS; Claudino R; Gonçalves MVM; Teixeira AL; de Godoy Rousseff Prado L; de Souza LC; Dourado MET; Oliveira ASB; Tumas V; França MC; Marques W
    Neurobiol Aging; 2018 Jun; 66():179.e1-179.e4. PubMed ID: 29449030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population.
    Cannas A; Solla P; Borghero G; Floris GL; Chio A; Mascia MM; Modugno N; Muroni A; Orofino G; Di Stefano F; Calvo A; Moglia C; Restagno G; Meloni M; Farris R; Ciaccio D; Puddu R; Vacca MI; Melis R; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Marrosu MG; Marrosu F
    J Neurol; 2015 Nov; 262(11):2498-503. PubMed ID: 26275564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis.
    Conforti FL; Spataro R; Sproviero W; Mazzei R; Cavalcanti F; Condino F; Simone IL; Logroscino G; Patitucci A; Magariello A; Muglia M; Rodolico C; Valentino P; Bono F; Colletti T; Monsurrò MR; Gambardella A; La Bella V
    Neurology; 2012 Dec; 79(24):2315-20. PubMed ID: 23197749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers.
    Gendron TF; van Blitterswijk M; Bieniek KF; Daughrity LM; Jiang J; Rush BK; Pedraza O; Lucas JA; Murray ME; Desaro P; Robertson A; Overstreet K; Thomas CS; Crook JE; Castanedes-Casey M; Rousseau L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Rademakers R; Lagier-Tourenne C; Edbauer D; Cleveland DW; Dickson DW; Petrucelli L; Boylan KB
    Acta Neuropathol; 2015 Oct; 130(4):559-73. PubMed ID: 26350237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermediate repeat expansion length in C9orf72 may be pathological in amyotrophic lateral sclerosis.
    Byrne S; Heverin M; Elamin M; Walsh C; Hardiman O
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Mar; 15(1-2):148-50. PubMed ID: 24053774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing.
    Le Ber I; Camuzat A; Guillot-Noel L; Hannequin D; Lacomblez L; Golfier V; Puel M; Martinaud O; Deramecourt V; Rivaud-Pechoux S; Millecamps S; Vercelletto M; Couratier P; Sellal F; Pasquier F; Salachas F; Thomas-Antérion C; Didic M; Pariente J; Seilhean D; Ruberg M; Wargon I; Blanc F; Camu W; Michel BF; Berger E; Sauvée M; Thauvin-Robinet C; Mondon K; Tournier-Lasserve E; Goizet C; Fleury M; Viennet G; Verpillat P; Meininger V; Duyckaerts C; Dubois B; Brice A
    J Alzheimers Dis; 2013; 34(2):485-99. PubMed ID: 23254636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study.
    Byrne S; Elamin M; Bede P; Shatunov A; Walsh C; Corr B; Heverin M; Jordan N; Kenna K; Lynch C; McLaughlin RL; Iyer PM; O'Brien C; Phukan J; Wynne B; Bokde AL; Bradley DG; Pender N; Al-Chalabi A; Hardiman O
    Lancet Neurol; 2012 Mar; 11(3):232-40. PubMed ID: 22305801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Axonal ion channel dysfunction in c9orf72 familial amyotrophic lateral sclerosis.
    Geevasinga N; Menon P; Howells J; Nicholson GA; Kiernan MC; Vucic S
    JAMA Neurol; 2015 Jan; 72(1):49-57. PubMed ID: 25384182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Definite behavioral variant of frontotemporal dementia with C9ORF72 expansions despite positive Alzheimer's disease cerebrospinal fluid biomarkers.
    Wallon D; Rovelet-Lecrux A; Deramecourt V; Pariente J; Auriacombe S; Le Ber I; Schraen S; Pasquier F; Campion D; Hannequin D
    J Alzheimers Dis; 2012; 32(1):19-22. PubMed ID: 22766732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C9ORF72 repeat expansion not detected in patients with multiple sclerosis.
    Fenoglio C; De Riz M; Villa C; Serpente M; Ridolfi E; Bonsi R; Cioffi SM; Barone C; Pietroboni A; Calvi A; Scarpini E; Galimberti D
    Neurobiol Aging; 2014 May; 35(5):1213.e1-2. PubMed ID: 24355526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72.
    Cooper-Knock J; Hewitt C; Highley JR; Brockington A; Milano A; Man S; Martindale J; Hartley J; Walsh T; Gelsthorpe C; Baxter L; Forster G; Fox M; Bury J; Mok K; McDermott CJ; Traynor BJ; Kirby J; Wharton SB; Ince PG; Hardy J; Shaw PJ
    Brain; 2012 Mar; 135(Pt 3):751-64. PubMed ID: 22366792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of
    Sokratous M; Lucia S; Bourinaris T; Marogianni C; Arnaoutoglou M; Patrikiou E; Ralli S; Markou A; Dardiotis E; Houlden H; Hadjigeorgiou GM; Xiromerisiou G
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Aug; 21(5-6):470-472. PubMed ID: 32338076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C9ORF72 hexanucleotide repeat expansions are a frequent cause of Huntington disease phenocopies in the Greek population.
    Koutsis G; Karadima G; Kartanou C; Kladi A; Panas M
    Neurobiol Aging; 2015 Jan; 36(1):547.e13-6. PubMed ID: 25248608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study.
    Majounie E; Renton AE; Mok K; Dopper EG; Waite A; Rollinson S; Chiò A; Restagno G; Nicolaou N; Simon-Sanchez J; van Swieten JC; Abramzon Y; Johnson JO; Sendtner M; Pamphlett R; Orrell RW; Mead S; Sidle KC; Houlden H; Rohrer JD; Morrison KE; Pall H; Talbot K; Ansorge O; ; ; ; Hernandez DG; Arepalli S; Sabatelli M; Mora G; Corbo M; Giannini F; Calvo A; Englund E; Borghero G; Floris GL; Remes AM; Laaksovirta H; McCluskey L; Trojanowski JQ; Van Deerlin VM; Schellenberg GD; Nalls MA; Drory VE; Lu CS; Yeh TH; Ishiura H; Takahashi Y; Tsuji S; Le Ber I; Brice A; Drepper C; Williams N; Kirby J; Shaw P; Hardy J; Tienari PJ; Heutink P; Morris HR; Pickering-Brown S; Traynor BJ
    Lancet Neurol; 2012 Apr; 11(4):323-30. PubMed ID: 22406228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Japanese amyotrophic lateral sclerosis patients with GGGGCC hexanucleotide repeat expansion in C9ORF72.
    Konno T; Shiga A; Tsujino A; Sugai A; Kato T; Kanai K; Yokoseki A; Eguchi H; Kuwabara S; Nishizawa M; Takahashi H; Onodera O
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):398-401. PubMed ID: 23012445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. De novo FUS gene mutations are associated with juvenile-onset sporadic amyotrophic lateral sclerosis in China.
    Zou ZY; Cui LY; Sun Q; Li XG; Liu MS; Xu Y; Zhou Y; Yang XZ
    Neurobiol Aging; 2013 Apr; 34(4):1312.e1-8. PubMed ID: 23046859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.